These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1681477)

  • 1. Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?
    Stutzmann JM; Eon B; Darche F; Lucas M; Rataud J; Piot O; Blanchard JC; Laduron PM
    Neurosci Lett; 1991 Jul; 128(1):4-8. PubMed ID: 1681477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
    Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.
    Pellow S; Johnston AL; File SE
    J Pharm Pharmacol; 1987 Nov; 39(11):917-28. PubMed ID: 2892916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
    Wright IK; Heaton M; Upton N; Marsden CA
    Psychopharmacology (Berl); 1992; 107(2-3):405-14. PubMed ID: 1352058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.
    Doble A; Girdlestone D; Piot O; Allam D; Betschart J; Boireau A; Dupuy A; Guérémy C; Ménager J; Zundel JL
    Br J Pharmacol; 1992 Jan; 105(1):27-36. PubMed ID: 1596688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptors.
    Fajolles C; Boireau A; Ponchant M; Laduron PM
    Eur J Pharmacol; 1992 May; 216(1):53-7. PubMed ID: 1526254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic mediation of the anxiolytic effect of intracerebrally injected propranolol measured in the elevated plus-maze.
    Audi EA; de-Oliveira CE; Graeff FG
    Braz J Med Biol Res; 1989; 22(6):699-701. PubMed ID: 2515907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists.
    Malleron JL; Comte MT; Gueremy C; Peyronel JF; Truchon A; Blanchard JC; Doble A; Piot O; Zundel JL; Huon C
    J Med Chem; 1991 Aug; 34(8):2477-83. PubMed ID: 1908521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin.
    Audi EA; de Oliveira RM; Graeff FG
    Psychopharmacology (Berl); 1991; 105(4):553-7. PubMed ID: 1685253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats.
    Stutzmann JM; Eon B; Lucas M; Blanchard JC; Laduron PM
    Sleep; 1992 Apr; 15(2):119-24. PubMed ID: 1579785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice.
    Brüning CA; Prigol M; Roehrs JA; Nogueira CW; Zeni G
    Behav Brain Res; 2009 Dec; 205(2):511-7. PubMed ID: 19683021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
    Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ
    Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel 5-HT2 receptor antagonist, RP 62203, selectively blocks serotoninergic but not dopaminergic-induced inhibition in the rat prefrontal cortex.
    Godbout R; Mantz J; Glowinski J; Thierry AM
    Eur J Pharmacol; 1991 Oct; 204(1):97-100. PubMed ID: 1666564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
    Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
    Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ritanserin on ethanol withdrawal-induced anxiety in rats.
    Gatch MB; Wallis CJ; Lal H
    Alcohol; 2000 May; 21(1):11-7. PubMed ID: 10946153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elevated T-maze as an experimental model of anxiety.
    Graeff FG; Netto CF; Zangrossi H
    Neurosci Biobehav Rev; 1998; 23(2):237-46. PubMed ID: 9884116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
    Peng WH; Wu CR; Chen CS; Chen CF; Leu ZC; Hsieh MT
    Life Sci; 2004 Oct; 75(20):2451-62. PubMed ID: 15350820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.
    Sławińska A; Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Uberti MA; Bacolod MA; Doller D; Pilc A
    Neuropharmacology; 2013 Mar; 66():225-35. PubMed ID: 22634361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.